Current cancer management involves chemotherapy, radiotherapy, and surgery, which induce unintended side effects compromising also health and well-being of patients. Emerging studies suggest that some Neutraceutical agents may impact cellular and molecular processes underlying tumor progression. However, some of Neutraceuticals might also play an antagonistic activity against Cancer and acts as classic therapeutic agents. Our current aim is to provide a wide range of nutraceuticals and furnish their underpinning use in cancer prevention and therapy.

Showing all 2 results